Home > Companies > PatientSafe Solutions

PatientSafe Solutions

PatientSafe Solutions helps care teams communicate and work together reliably and efficiently through a mobile platform that unites clinical communication with workflows in one application, on one device. PatientTouch delivers secure messages, voice calls, critical alerts and nurse calls to a unified inbox prioritized for each care team member. The platform extends to include clinical workflows like rounding, specimen collection, sepsis and nursing documentation. Deeply integrated with the EMR, clinical, and directory systems, PatientTouch provides real-time patient, clinical and care team context for more efficient care collaboration and decision making. For more than a decade, PatientTouch has helped clinicians both in and outside the hospital streamline care delivery, increase quality and lower costs. For more information, please visit patientsafesolutions.com.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

5th International Conference on Glycobiology

Conference

The Trace Elements in Biology and Medicine Conference

Conference

Pediatric Infectious Diseases: A Primary Care and Hospitalist Approach

Conference

Role of Risk Stratification for Cardio Vascular Disease in the COVID-19 era and its economic benefits

Webinar

World Congress on Precision and Personalized Medicine

Conference

4th International Conference on Medical and Health Sciences

Conference

Related News

SARTORIUS STEDIM BIOTECH CLOSES ACQUISITION OF SLOVENIAN PURIFICATION SPECIALIST BIA SEPARATIONS

Sartorius | November 03, 2020

Sartorius Stedim Biotech (SSB), a leading partner of the biopharma industry, successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the required approvals. "BIA's portfolio is highly complementary to Sartorius Stedim Biotech. We are thus creating an excellent offering for the manufacturing of gene therapies and other advanced therapies, and are pleased to welcome 120 new employees,&...

PROTECTIVE CLOTHING FOR LIFE SCIENCES INDUSTRY GLOBAL MARKET TO WITNESS GROWTH IN BIOTECHNOLOGY AND HEALTHCARE SPENDING BY 2028

Research And Markets | June 30, 2020

The "Global Protective Clothing Market for Life Sciences Industry 2019-2028" report has been added to ResearchAndMarkets.com's offering.The publisher predicts that the global market for protective clothing for life sciences industry would witness a CAGR of 6.26% over the forecast period 2019-2028.The growth of this market is primarily being driven by the growing demand for protective clothing from end-users. Additionally, the large investments in research & developm...

INDUSTRIAL IMPACT

LEGEND BIOTECH ANNOUNCES EXTENSION OF PDUFA DATE FOR CILTA-CEL

Cilta-cel | November 01, 2021

Legend Biotech Corporation (Legend Biotech), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, today announced that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act (PDUFA) target date for ciltacabtagene autoleucel (cilta-cel) to February 28, 2022. Cilta-cel is a BCMA-directed chimeric antigen receptor T cell (CAR-T) therapy being investigated for the treatment of adults with relapsed and/or refractory multiple myelo...

INDUSTRIAL IMPACT

MERAKRIS AND DEPT. OF VETERANS AFFAIRS SIGN CRADA AGREEMENT – CLINICAL TRIAL FOR DERMACYTE® WOUND CARE PRODUCT TO BEGIN SOON

Merakris Therapeutics | February 09, 2022

Merakris Therapeutics announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Department of Veterans Affairs (VA) to test its investigational drug product, Dermacyte® Amniotic Wound Care Liquid. The VA plans to enroll patients, ages 18-75, in a two-part Phase II clinical study to evaluate Merakris’ first in class subcutaneous – or below the skin – injectable wound healing therapy. The study is designe...